The bidirectional link between type I IFN and trained immunity provides a rationale for alternative treatment strategies and contributes to the understanding of the pathogenesis of atherosclerosis in patients with pSS and other IFN-associated systemic autoimmune diseases. The gene discussed is IFNA1; the disease is atherosclerosis.